Skip to the page

Data / Form D filings / REPLICEL LIFE SCIENCES INC.

REPLICEL LIFE SCIENCES INC.: Form D filings

REPLICEL LIFE SCIENCES INC., a technology company in Vancouver Bc, British Columbia, Canada, filed 24 Form D notices with the SEC between 2012 and 2024. The latest, on December 16, 2024, reports $223,665 sold of a $223,665 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
SUITE 900 - 570 GRANVILLE STREET, Vancouver Bc, British Columbia, Canada, V6C 3
Phone
(604) 248-8693
Industry
Other Technology
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1205059

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 16, 2024New notice$223,665$223,6652Nov 26, 2024sec.gov
Mar 16, 2023New notice$740,778$740,7785Mar 14, 2023sec.gov
Feb 8, 2023New notice$9,196$9,1961Feb 1, 2023sec.gov
Jan 26, 2023New notice$86,942$86,9422Jan 17, 2023sec.gov
Jan 6, 2023New notice$558,837$558,8372Dec 30, 2022sec.gov
May 10, 2022New notice$592,728$592,7282May 4, 2022sec.gov
Dec 20, 2021New notice$777,659$777,6591Dec 17, 2021sec.gov
Jun 14, 2021Amendment$161,520$161,5203Jun 2, 2021sec.gov
Jun 3, 2021New notice$111,574$111,5742Jun 2, 2021sec.gov
May 27, 2021New notice$9,012$9,0121May 17, 2021sec.gov
Feb 26, 2021New notice$385,848$385,8481Feb 8, 2021sec.gov
Aug 20, 2020New notice$118,181$118,1812Aug 18, 2020sec.gov
Jul 24, 2020New notice$447,064$447,0642Jul 15, 2020sec.gov
Nov 4, 2019New notice$135,078$135,0781Oct 29, 2019sec.gov
Sep 13, 2019New notice$76,030$76,0301Sep 10, 2019sec.gov
Jan 22, 2019New notice$20,883$20,8831Jan 15, 2019sec.gov
Oct 26, 2017New notice$267,158$267,1582Oct 19, 2017sec.gov
Jan 9, 2017New notice$8,536$8,5361Dec 28, 2016sec.gov
Nov 8, 2016New notice$112,274$112,2743Oct 28, 2016sec.gov
Jul 6, 2015New notice$143,033$143,0333Jun 25, 2015sec.gov
Apr 19, 2013New notice$70,210$70,2102Apr 10, 2013sec.gov
May 24, 2012New notice$245$2451May 17, 2012sec.gov
Apr 25, 2012New notice$594,050$594,0506Apr 18, 2012sec.gov
Apr 4, 2012New notice$272,998$272,9986Mar 29, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jamie MackayDirector
Peter LewisDirector
David KwokExecutive Officer
Ben AustringExecutive Officer
Gary BoddingtonDirector
David HallExecutive Officer, Director
Lee BucklerDirector
Andrew SchutteExecutive Officer, Director
Kevin McElweeExecutive Officer

Every Form D from the week of Dec 16, 2024 · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what REPLICEL LIFE SCIENCES INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.